Literature DB >> 24753048

An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.

Rheaclare Fraser1, Yongyue Chen1, Bipasha Guptaroy1, Kathryn D Luderman1, Stephanie L Stokes1, Asim Beg1, Louis J DeFelice1, Margaret E Gnegy2.   

Abstract

The dopamine transporter (DAT) reversibly transports dopamine (DA) through a series of conformational transitions. Alanine (T62A) or aspartate (T62D) mutagenesis of Thr62 revealed T62D-human (h)DAT partitions in a predominately efflux-preferring conformation. Compared with wild-type (WT), T62D-hDAT exhibits reduced [(3)H]DA uptake and enhanced baseline DA efflux, whereas T62A-hDAT and WT-hDAT function in an influx-preferring conformation. We now interrogate the basis of the mutants' altered function with respect to membrane conductance and Na(+) sensitivity. The hDAT constructs were expressed in Xenopus oocytes to investigate if heightened membrane potential would explain the efflux characteristics of T62D-hDAT. In the absence of substrate, all constructs displayed identical resting membrane potentials. Substrate-induced inward currents were present in oocytes expressing WT- and T62A-hDAT but not T62D-hDAT, suggesting equal bidirectional ion flow through T62D-hDAT. Utilization of the fluorescent DAT substrate ASP(+) [4-(4-(dimethylamino)styryl)-N-methylpyridinium] revealed that T62D-hDAT accumulates substrate in human embryonic kidney (HEK)-293 cells when the substrate is not subject to efflux. Extracellular sodium (Na(+) e) replacement was used to evaluate sodium gradient requirements for DAT transport functions. The EC50 for Na(+) e stimulation of [(3)H]DA uptake was identical in all constructs expressed in HEK-293 cells. As expected, decreasing [Na(+)]e stimulated [(3)H]DA efflux in WT- and T62A-hDAT cells. Conversely, the elevated [(3)H]DA efflux in T62D-hDAT cells was independent of Na(+) e and commensurate with [(3)H]DA efflux attained in WT-hDAT cells, either by removal of Na(+) e or by application of amphetamine. We conclude that T62D-hDAT represents an efflux-willing, Na(+)-primed orientation-possibly representing an experimental model of the conformational impact of amphetamine exposure to hDAT.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24753048      PMCID: PMC4053999          DOI: 10.1124/mol.114.091926

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  42 in total

Review 1.  The functional impact of SLC6 transporter genetic variation.

Authors:  Maureen K Hahn; Randy D Blakely
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

Review 2.  Transporters as channels.

Authors:  Louis J DeFelice; Tapasree Goswami
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

3.  Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors.

Authors:  Agustin Zapata; Bronwyn Kivell; Yang Han; Jonathan A Javitch; Elizabeth A Bolan; David Kuraguntla; Vanaja Jaligam; Murat Oz; Lankupalle D Jayanthi; Devadoss J Samuvel; Sammanda Ramamoorthy; Toni S Shippenberg
Journal:  J Biol Chem       Date:  2007-10-08       Impact factor: 5.157

4.  Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters.

Authors:  Atsuko Yamashita; Satinder K Singh; Toshimitsu Kawate; Yan Jin; Eric Gouaux
Journal:  Nature       Date:  2005-07-24       Impact factor: 49.962

5.  Differences in interactions with the dopamine transporter as revealed by diminishment of Na(+) gradient and membrane potential: dopamine versus other substrates.

Authors:  Juan Zhen; Nianhang Chen; Maarten E A Reith
Journal:  Neuropharmacology       Date:  2005-08-24       Impact factor: 5.250

6.  Dopamine transporters depolarize neurons by a channel mechanism.

Authors:  Lucia Carvelli; Paul W McDonald; Randy D Blakely; Louis J DeFelice
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-01       Impact factor: 11.205

7.  Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter.

Authors:  Anne-Kristine Meinild; Harald H Sitte; Ulrik Gether
Journal:  J Biol Chem       Date:  2004-09-09       Impact factor: 5.157

8.  Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function.

Authors:  Kevin Erreger; Christof Grewer; Jonathan A Javitch; Aurelio Galli
Journal:  J Neurosci       Date:  2008-01-23       Impact factor: 6.167

9.  An intracellular interaction network regulates conformational transitions in the dopamine transporter.

Authors:  Julie Kniazeff; Lei Shi; Claus J Loland; Jonathan A Javitch; Harel Weinstein; Ulrik Gether
Journal:  J Biol Chem       Date:  2008-04-21       Impact factor: 5.157

10.  Anomalous dopamine release associated with a human dopamine transporter coding variant.

Authors:  Michelle S Mazei-Robison; Erica Bowton; Marion Holy; Martin Schmudermaier; Michael Freissmuth; Harald H Sitte; Aurelio Galli; Randy D Blakely
Journal:  J Neurosci       Date:  2008-07-09       Impact factor: 6.167

View more
  6 in total

1.  Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency.

Authors:  Richard B Rothman; Subramaniam Ananthan; John S Partilla; Surendra K Saini; Omar Moukha-Chafiq; Vibha Pathak; Michael H Baumann
Journal:  J Pharmacol Exp Ther       Date:  2015-03-18       Impact factor: 4.030

Review 2.  Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.

Authors:  Daniel P Bermingham; Randy D Blakely
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 3.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

Review 4.  Chloride requirement for monoamine transporters.

Authors:  Louis J De Felice
Journal:  Pflugers Arch       Date:  2016-01-22       Impact factor: 3.657

5.  Molecular basis for the interaction of the mammalian amino acid transporters B0AT1 and B0AT3 with their ancillary protein collectrin.

Authors:  Stephen J Fairweather; Angelika Bröer; Nandhitha Subramanian; Emrah Tumer; Qi Cheng; Dieter Schmoll; Megan L O'Mara; Stefan Bröer
Journal:  J Biol Chem       Date:  2015-08-03       Impact factor: 5.157

6.  Dopamine Transporter Activity Is Modulated by α-Synuclein.

Authors:  Brittany Butler; Kaustuv Saha; Tanu Rana; Jonas P Becker; Danielle Sambo; Paran Davari; J Shawn Goodwin; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2015-10-06       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.